‪Brian R. Edlin, MD, FACP, FIDSA, FAASLD‬

Citeras av

	Alla	Sedan 2020
Citat	15628	2674
h-index	63	24
i10-index	110	52

760

380

190

570

19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202597 139 192 201 239 231 252 309 307 365 333 410 607 544 634 563 570 641 522 533 684 759 754 727 707 648 619 657 648 549 415 371 32

Offentlig åtkomst

Visa alla

37 artiklar

0 artiklar

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

Dan CiccaroneUniversity of California, San FranciscoVerifierad e-postadress på ucsf.edu
Barbara RehermannChief, Immunology Section, Liver Diseases Branch, NIDDK, NIHVerifierad e-postadress på nih.gov
Ludmila Prokunina-OlssonNational Cancer Institute, National Institutes of HealthVerifierad e-postadress på mail.nih.gov
Emilia Mia Sordillo, MD, PhDProfessor, Pathology, Molecular & Cell Based Medicine, Icahn School of Medicine at MountVerifierad e-postadress på mountsinai.org
Benjamin EckhardtNYU School of MedicineVerifierad e-postadress på nyumc.org
Robert A WeinsteinProfessor of Medicine, Rush University Medical CenterVerifierad e-postadress på rush.edu
Kenneth CastroEmory University Department of Global HealthVerifierad e-postadress på emory.edu
James InciardiSociology & Criminal Justice, University of Delaware
Edward MurphyUCSFVerifierad e-postadress på ucsf.edu
Philippe BourgoisUniversity of California, Los AngelesVerifierad e-postadress på ucla.edu
Jonathan MerminCDCVerifierad e-postadress på cdc.gov
Kimberly PageUniversity of New Mexico Health Sciences CenterVerifierad e-postadress på salud.unm.edu
Eric C SeabergJohns Hopkins Bloomberg School of Public HealthVerifierad e-postadress på jhu.edu
David BangsbergProvost and Dean College of Health Sciences, VinUniversityVerifierad e-postadress på vinuni.edu.vn
Eric DelwartVitalant Research Institute & UCSFVerifierad e-postadress på medicine.ucsf.edu
Judith A HahnProfessor in Residence, University of California San FranciscoVerifierad e-postadress på ucsf.edu
Robert ShaferProfessor of Medicine, Stanford UniversityVerifierad e-postadress på stanford.edu
Michael J CannonCenters for Disease Control and PreventionVerifierad e-postadress på cdc.gov
Scott BurrisTemple University Beasley School of LawVerifierad e-postadress på temple.edu
Eric A EngelsSenior Investigator, National Cancer InstituteVerifierad e-postadress på exchange.nih.gov

Följ

Brian R. Edlin, MD, FACP, FIDSA, FAASLD

Centers for Disease Control and Prevention, Weill Cornell Medical College

Verifierad e-postadress på cdc.gov - Startsida

infectious diseases public health hepatitis C harm reduction epidemiology


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome BR Edlin, JI Tokars, MH Grieco, JT Crawford, J Williams, EM Sordillo, ... New England Journal of Medicine 326 (23), 1514-1521, 1992	1236	1992
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus L Prokunina-Olsson, B Muchmore, W Tang, RM Pfeiffer, H Park, ... Nature genetics 45 (2), 164-171, 2013	1140	2013
Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults BR Edlin, KL Irwin, S Faruque, CB McCoy, C Word, Y Serrano, JA Inciardi, ... New England Journal of Medicine 331 (21), 1422-1427, 1994	764*	1994
Estimating prevalence of hepatitis C virus infection in the United States, 2013‐2016 MG Hofmeister, EM Rosenthal, LK Barker, ES Rosenberg, MA Barranco, ... Hepatology 69 (3), 1020-1031, 2019	552	2019
Toward a more accurate estimate of the prevalence of hepatitis C in the United States BR Edlin, BJ Eckhardt, MA Shu, SD Holmberg, T Swan Hepatology 62 (5), 1353-1363, 2015	494	2015
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment‐naive patients T Kuntzen, J Timm, A Berical, N Lennon, AM Berlin, SK Young, B Lee, ... Hepatology 48 (6), 1769-1778, 2008	434	2008
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis AH Kral, RN Bluthenthal, J Lorvick, L Gee, P Bacchetti, BR Edlin The Lancet 357 (9266), 1397-1401, 2001	432	2001
High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco IA Binswanger, AH Kral, RN Bluthenthal, DJ Rybold, BR Edlin Clinical infectious diseases 30 (3), 579-581, 2000	364	2000
Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial NE Soifer, S Borzak, BR Edlin, RA Weinstein Archives of Internal Medicine 158 (5), 473-477, 1998	363	1998
Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study EL Murphy, D DeVita, H Liu, E Vittinghoff, P Leung, DH Ciccarone, ... Clinical Infectious Diseases 33 (1), 35-40, 2001	312	2001
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? BR Edlin, KH Seal, J Lorvick, AH Kral, DH Ciccarone, LD Moore, B Lo The New England journal of medicine 345 (3), 211, 2001	303	2001
Sex trading and psychological distress among women recruited from the streets of Harlem. N El-Bassel, RF Schilling, KL Irwin, S Faruque, L Gilbert, J Von Bargen, ... American Journal of Public Health 87 (1), 66-70, 1997	303	1997
Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study KH Seal, R Thawley, L Gee, J Bamberger, AH Kral, D Ciccarone, ... Journal of Urban Health 82, 303-311, 2005	296	2005
Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade RW Shafer, BR Edlin Clinical infectious diseases 22 (4), 683-704, 1996	292	1996
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus H Masur, JE Kaplan, KK Holmes, BL Alston, N Ampel, JR Anderson, ... Clinical Infectious Diseases 30, S29-S65, 2000	287*	2000
The effect of syringe exchange use on high-risk injection drug users: a cohort study RN Bluthenthal, AH Kral, L Gee, EA Erringer, BR Edlin AIDS 14 (5), 605-611, 2000	285	2000
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users BR Edlin, TF Kresina, DB Raymond, MR Carden, MN Gourevitch, JD Rich, ... Clinical infectious diseases 40 (Supplement_5), S276-S285, 2005	276	2005
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ... Annals of internal medicine 158 (4), 235-245, 2013	258	2013
Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999 KH Seal, AH Kral, L Gee, LD Moore, RN Bluthenthal, J Lorvick, BR Edlin American journal of public health 91 (11), 1842-1846, 2001	236	2001
Prevention and treatment of hepatitis C in injection drug users BR Edlin Hepatology 36 (S1), S210-S219, 2002	235	2002

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare